Legal questions stall consolidation plan

WASHINGTON - Plans to consolidate reviews of applications to conduct gene therapy trials are in a state of suspended animation pending the outcome of efforts by FDA and NIH lawyers to find a legal way to implement them.

The NIH's Recombinant DNA Advisory

Read the full 425 word article

How to gain access

Continue reading with a
two-week free trial.